OCS DCD Heart + CAP Continued Follow-Up

Active, not recruitingOBSERVATIONAL
Enrollment

276

Participants

Timeline

Start Date

November 26, 2019

Primary Completion Date

October 31, 2026

Study Completion Date

October 31, 2026

Conditions
Heart Transplant
Interventions
DEVICE

OCS Heart

Transplanted with OCS preserved heart.

Trial Locations (20)

10032

Nyph/Cumc, New York

10467

Montefiore, The Bronx

23502

Sentara, Norfolk

27710

Duke University, Durham

30322

Emory University Hospital, Atlanta

32224

Mayo Clinic Florida, Jacksonville

32803

AdventHealth Orlando, Orlando

37232

Vanderbilt Medical Center, Nashville

46260

St. Vincent Cardiovascular Research Institute, Indianapolis

53226

Froedtert & the Medical College of Wisconsin, Milwaukee

53792

University of Wisconsin, Madison

55407

Minneapolis Heart Institute, Minneapolis

55414

University of Minnesota, Minneapolis

60611

Northwestern Medicine, Chicago

68198

University of Nebraska Medical Center, Omaha

92037

University of California San Diago, La Jolla

94304

Stanford University, Palo Alto

06510

Yale New Haven Hospital, New Haven

02111

Tufts Medical Center, Boston

02114

Massachusetts General Hospital, Boston

Sponsors

Lead Sponsor

All Listed Sponsors
lead

TransMedics

INDUSTRY

NCT05741723 - OCS DCD Heart + CAP Continued Follow-Up | Biotech Hunter | Biotech Hunter